Lexeo Therapeutics Inc.
LXEO
Get informed when a big investor buys or sells
+ FollowMarket Cap$381.62M
Close$
$1.03
78.5% downside
Current Fair Value
78.5% downsideOvervalued by 78.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $381.62 Million |
|---|---|
| Enterprise Value | $295.59 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.86 |
| Beta | 1.47 |
| Outstanding Shares | 85,626,751 |
Return
| Return on Equity | -37.12% |
|---|---|
| Return on Assets | -34.24% |
| Return on Invested Capital | 12.85% |
Valuation & Multiples
| P/E Ratio | -4.23 |
|---|---|
| PEG | 467.43 |
| Price to Sales | - |
| Price to Book Ratio | 2.39 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 9.62 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$-0.29
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
December 14, 2026
EPS Estimate
$-0.33
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1513▼ 84.05% |
|---|---|
| Total Calls | 66,100▲ 441.80% |
| Total Puts | 10,000▼ 17.36% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 98.41%▼ 1.73% |
|---|---|
| Total Invested | $458.73M▼ 39.58% |
| Investors Holding | 143▼ 5.00% |
ESG Score
No data